company background image
LASA logo

Lasa Supergenerics NSEI:LASA Stock Report

Last Price

₹23.38

Market Cap

₹1.2b

7D

9.3%

1Y

3.2%

Updated

13 Jun, 2024

Data

Company Financials

Lasa Supergenerics Limited

NSEI:LASA Stock Report

Market Cap: ₹1.2b

LASA Stock Overview

Engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India.

LASA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends2/6

Lasa Supergenerics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lasa Supergenerics
Historical stock prices
Current Share Price₹23.38
52 Week High₹41.20
52 Week Low₹19.00
Beta0.41
1 Month Change-2.38%
3 Month Change-1.14%
1 Year Change3.22%
3 Year Change-72.15%
5 Year Change53.82%
Change since IPO-84.12%

Recent News & Updates

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jun 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Mar 13
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Recent updates

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jun 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Mar 13
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding

Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

Dec 28
Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified

We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Jul 05
We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt

Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Mar 28
Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt

Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Sep 02
Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25

Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

Aug 13
Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?

A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Jun 21
A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)

Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

Dec 06
Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?

Shareholder Returns

LASAIN PharmaceuticalsIN Market
7D9.3%3.3%5.1%
1Y3.2%56.1%43.8%

Return vs Industry: LASA underperformed the Indian Pharmaceuticals industry which returned 56.1% over the past year.

Return vs Market: LASA underperformed the Indian Market which returned 43.8% over the past year.

Price Volatility

Is LASA's price volatile compared to industry and market?
LASA volatility
LASA Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.7%
10% most volatile stocks in IN Market9.8%
10% least volatile stocks in IN Market4.5%

Stable Share Price: LASA has not had significant price volatility in the past 3 months.

Volatility Over Time: LASA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201689Omkar Herlekarlasalabs.com

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide.

Lasa Supergenerics Limited Fundamentals Summary

How do Lasa Supergenerics's earnings and revenue compare to its market cap?
LASA fundamental statistics
Market cap₹1.17b
Earnings (TTM)-₹217.31m
Revenue (TTM)₹1.04b

1.1x

P/S Ratio

-5.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LASA income statement (TTM)
Revenue₹1.04b
Cost of Revenue₹752.18m
Gross Profit₹292.17m
Other Expenses₹509.47m
Earnings-₹217.31m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-4.34
Gross Margin27.98%
Net Profit Margin-20.81%
Debt/Equity Ratio22.8%

How did LASA perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.